Iteos Therapeutics Inc (ITOS) — Cash Flow Reinvestment Rate
Iteos Therapeutics Inc (ITOS) has a Cash Flow Reinvestment Rate of 2.50x as of December 2024, reinvesting $13.77 Million (capex $152.00K plus investments $13.62 Million) from operating cash flow of $5.50 Million. Check ITOS cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Iteos Therapeutics Inc Cash Flow Reinvestment Rate (2021–2021)
Historical reinvestment intensity for Iteos Therapeutics Inc across 1 annual periods. Explore ITOS long-term investment intensity to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Iteos Therapeutics Inc (2021–2021)
Year-by-year capital reinvestment analysis for Iteos Therapeutics Inc. For live market cap and broader valuation context, see market cap of Iteos Therapeutics Inc.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2021 | 0.00x | $2.42 Million | $513.14 Million | $1.18 Million | — |